Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 10:51 PM
Study NCT ID:
NCT01611467
Status:
COMPLETED
Last Update Posted:
2019-11-12
First Post:
2012-05-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Pharmacokinetics of CC-223 in Healthy Male Adult Subjects
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2012-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-25
First Submit QC Date:
None
Study First Post Date:
2012-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-07
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL